Our Covid-19 rapid anti-body test kit has gained coveted EU and UK regulatory approval for a rapid test kit that shows whether patients and those in social care settings have had Covid-19 Coronavirus – even if they did not develop obvious symptoms at the time.
The point of care test, which is only for use by healthcare professionals, uses a fingertip blood sample to detect the presence of antibodies produced by the body’s immune system that lasts long after the initial infection. A positive or negative result is shown within 10 to 15 minutes.
The test kits have now received coveted ‘CE’ certification for their conformity with all EU medical diagnostic device health protection directives. Product registration approval has also been confirmed by the UK’s Medicines & Healthcare products Regulatory Agency (MHRA).
While not a test for current Covid-19 infection, the rapid test kit achieves an accuracy rate of 94.68% when compared against that achieved by more complex laboratory tests. It can be used to help confirm whether hospitals and care workers, or those in their care, have had the virus. Data collected from test results can then be used to investigate the past spread of the virus or further inform safe working practices.
The test kits are part of a range of COVID-related products available from Multibrands International. Since the start of the Covid-19 pandemic, Multibrands International has invested over £12m into the production of its PPE equipment brands, Panodyne to support the ongoing battle to tackle the virus and stop the spread of infection.
All products in the Panodyne range have been carefully researched and designed in the UK, and the Panodyne brand has since become a trusted UK supplier of high-quality PPE equipment, including certified, medical-grade Type I and Type II R facemasks, hand sanitizers, disposable gloves and other specialist PPE items that are fully tested to the highest European standards.
Overall, we have invested over £12m into our Panodyne Range since the outbreak began in China. As we have facilities based in China, we were able to provide early support and also be on the front-foot in predicting a global need. Of course, we never could have predicted a global shut down, but we are proud to be able to able to support the world’s efforts in tackling this deadly virus.
For more information on Panodyne and Multibrands International, click here.